TIPARP and prostate cancer: While small androgen-induced changes (up and down) were apparent for a few Parps, the only Parp whose expression increased >2-fold in both prostate cancer lines was the mono-ADP-ribosyltransferase Tiparp (Parp7; Fig. 3a).